Report of Foreign Issuer (6-k)
July 25 2018 - 6:09AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE
SECURITIES EXCHANGE ACT OF 1934
For the month of, July 2018
Commission File Number 001-37652
Midatech
Pharma PLC
(Translation of registrant’s name
into English)
65 Innovation Drive
Milton Park
Abingdon, Oxfordshire, OX14 4RQ, United
Kingdom
(Address of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
SUBMITTED
HEREWITH
Attached
to the Registrant’s Form 6-K filing for the month of July 2018, and incorporated by reference herein, is:
|
|
|
Exhibit No.
|
|
Description
|
|
|
99.1
|
|
Press
release, dated July 25, 2018 entitled “Trading Update.”
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
Midatech
Pharma PLC
|
|
|
|
|
|
|
|
|
|
Date:
July 25, 2018
|
|
|
|
By:
|
|
/s/
Nicholas Robbins-Cherry
|
|
|
|
|
|
|
|
|
Nicholas
Robbins-Cherry
Chief
Financial Officer
|
Exhibit
Index
Exhibit No.
|
|
Description
|
|
|
99.1
|
|
Press
release, dated July 25, 2018 entitled “Trading Update.”
|
Midatech Pharma (NASDAQ:MTP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Midatech Pharma (NASDAQ:MTP)
Historical Stock Chart
From Apr 2023 to Apr 2024